Roksolana Denina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roksolana Denina has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Nestor Seredyuk
Ivano-Frankivsk national medical University, Department of internal medicine №2 and nursing, Ivano-Frankivsk, Ukraine
6 shared publications - Oleksii Skakun
Cardiological Department, St. Luke’s Clinic, Ivano-Frankivsk, Ukraine
6 shared publications - Yaroslava Vandzhura
Department of Internal Medicine No. 2 and Nursing, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
6 shared publications - Ihor Vandzhura
Department of Internal Medicine No. 2 and Nursing, Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
5 shared publications - P. P. Zvonar
Ivano-Frankivsk National Medical University
5 shared publications - Mykyta Bielinskyi
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
3 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 35-40
PR INTERVAL ON RESTING ECG IN PATIENTS WITH MOBITZ-1 SECOND-DEGREE ATRIOVENTRICULAR BLOCK DETECTED ON AMBULATORY ECG MONITORING
Prolonged PR interval is traditionally regarded as an electrocardiographic marker of delayed atrioventricular conduction and is known to predict future episodes of second- and third-degree atrioventricular block. Nevertheless, clinically significant episodes of second- and third-degree atrioventricular block may also occur in individuals with a normal PR interval on a standard resting electrocardiogram (ECG), indicating that normal baseline atrioventricular conduction does not exclude intermittent conduction abnormalities. Although Mobitz-1 second-degree atrioventricular block has long been considered a relatively benign rhythm disturbance, recent evidence has challenged this concept. A contemporary study demonstrated that the presence of Mobitz-1 atrioventricular block was associated with a 2.3-fold increase in the rate of cardiovascular death, suggesting that this conduction disorder may have greater clinical significance than previously believed. Current clinical guidelines recommend permanent pacemaker implantation for patients with Mobitz-2 second-degree atrioventricular block, infranodal 2:1 atrioventricular block, high-degree atrioventricular block, and third-degree atrioventricular block regardless of symptom status because of the substantial risk of progression to complete heart block. In contrast, permanent pacing in patients with Mobitz-1 second-degree atrioventricular block is generally indicated for those with symptoms attributable to bradycardia or for patients in whom electrophysiological evaluation demonstrates an intra-Hisian or infra-Hisian site of conduction delay. The study aimed to evaluate the relationship between the PR interval measured on a resting ECG and the occurrence of Mobitz-1 second-degree atrioventricular block detected by ambulatory ECG monitoring. Recordings from ambulatory ECG monitoring and corresponding resting ECGs of 40 patients with documented Mobitz-1 second-degree atrioventricular block were retrospectively analyzed. The median maximal PR interval recorded during ambulatory monitoring was 245.0 [212.5–305.0] ms, while the median maximal RR interval was 2038.0 [1819.0–2356.0] ms. On resting ECG, the median PR interval was 205.0 [167.5–245.0] ms. A prolonged PR interval (≥200 ms) on resting ECG was identified in 22 patients (55.0 %). Among these individuals, only 7 (17.5 %) patients had mild PR interval prolongation ranging from 200 to 220 ms, whereas the remaining patients exhibited more pronounced prolongation. Importantly, a normal PR interval (<200 ms) on resting ECG was observed in 18 patients (45.0 %) despite documented episodes of Mobitz-1 second-degree atrioventricular block during ambulatory ECG monitoring. There was a strong positive correlation was found between the PR interval measured on resting ECG and the maximal PR interval recorded during ambulatory monitoring (r = 0.76, p < 0.01). These findings demonstrate that nearly half of patients with Mobitz-1 second-degree atrioventricular block documented by ambulatory ECG monitoring have a normal PR interval on resting ECG. Consequently, the PR interval measured on a resting ECG should not be considered a reliable marker for excluding episodic Mobitz-1 second-degree atrioventricular block. Ambulatory ECG monitoring remains an essential diagnostic tool for detecting intermittent atrioventricular conduction disturbances that may not be apparent during routine resting ECG.
- 30 September 2026
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 35-40
Open AccessPR INTERVAL ON RESTING ECG IN PATIENTS WITH MOBITZ-1 SECOND-DEGREE ATRIOVENTRICULAR BLOCK DETECTED ON AMBULATORY ECG MONITORING
Prolonged PR interval is traditionally regarded as an electrocardiographic marker of delayed atrioventricular conduction and is known to predict future episodes of second- and third-degree atrioventricular block. Nevertheless, clinically significant episodes of second- and third-degree atrioventricular block may also occur in individuals with a normal PR interval on a standard resting electrocardiogram (ECG), indicating that normal baseline atrioventricular conduction does not exclude intermittent conduction abnormalities. Although Mobitz-1 second-degree atrioventricular block has long been considered a relatively benign rhythm disturbance, recent evidence has challenged this concept. A contemporary study demonstrated that the presence of Mobitz-1 atrioventricular block was associated with a 2.3-fold increase in the rate of cardiovascular death, suggesting that this conduction disorder may have greater clinical significance than previously believed. Current clinical guidelines recommend permanent pacemaker implantation for patients with Mobitz-2 second-degree atrioventricular block, infranodal 2:1 atrioventricular block, high-degree atrioventricular block, and third-degree atrioventricular block regardless of symptom status because of the substantial risk of progression to complete heart block. In contrast, permanent pacing in patients with Mobitz-1 second-degree atrioventricular block is generally indicated for those with symptoms attributable to bradycardia or for patients in whom electrophysiological evaluation demonstrates an intra-Hisian or infra-Hisian site of conduction delay. The study aimed to evaluate the relationship between the PR interval measured on a resting ECG and the occurrence of Mobitz-1 second-degree atrioventricular block detected by ambulatory ECG monitoring. Recordings from ambulatory ECG monitoring and corresponding resting ECGs of 40 patients with documented Mobitz-1 second-degree atrioventricular block were retrospectively analyzed. The median maximal PR interval recorded during ambulatory monitoring was 245.0 [212.5–305.0] ms, while the median maximal RR interval was 2038.0 [1819.0–2356.0] ms. On resting ECG, the median PR interval was 205.0 [167.5–245.0] ms. A prolonged PR interval (≥200 ms) on resting ECG was identified in 22 patients (55.0 %). Among these individuals, only 7 (17.5 %) patients had mild PR interval prolongation ranging from 200 to 220 ms, whereas the remaining patients exhibited more pronounced prolongation. Importantly, a normal PR interval (<200 ms) on resting ECG was observed in 18 patients (45.0 %) despite documented episodes of Mobitz-1 second-degree atrioventricular block during ambulatory ECG monitoring. There was a strong positive correlation was found between the PR interval measured on resting ECG and the maximal PR interval recorded during ambulatory monitoring (r = 0.76, p < 0.01). These findings demonstrate that nearly half of patients with Mobitz-1 second-degree atrioventricular block documented by ambulatory ECG monitoring have a normal PR interval on resting ECG. Consequently, the PR interval measured on a resting ECG should not be considered a reliable marker for excluding episodic Mobitz-1 second-degree atrioventricular block. Ambulatory ECG monitoring remains an essential diagnostic tool for detecting intermittent atrioventricular conduction disturbances that may not be apparent during routine resting ECG.
- Open Access
- 1 July 2026
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 19, 1-6
Temporary Rhythm Control with Flecainide in Atrial Fibrillation-Related Conversion Pauses Prior to Catheter Ablation: A Case of Successful Pharmacological Bridging
The management of paroxysmal atrial fibrillation with conversion pauses remains challenging, with catheter ablation and permanent pacemaker implantation representing the main therapeutic strategies. Catheter ablation may eliminate atrial fibrillation paroxysms and prevent conversion pauses, whereas pacemaker implantation combined with antiarrhythmic therapy for rhythm control is another accepted option. We report a case of successful management of paroxysmal atrial fibrillation with conversion pauses using antiarrhythmic agents for rhythm control prior to catheter ablation. A 61-year-old woman had episodes of palpitations, dizziness, and presyncope. Ambulatory 12-lead 24-hour ECG monitoring showed 51 episodes of atrial fibrillation and atrial flutter with conversion pauses after each of them; the longest pause was 7460 ms. Atrial fibrillation lasted for 46.9% of the total monitoring time. When ambulatory 24-hour monitoring was performed, the patient was highly symptomatic (complaints of palpitations and fear of death were predominant, but dizziness episodes were also noted). Catheter ablation was unavailable in the short-term period and permanent pacemaker implantation was not accepted by the patient. Thus, flecainide at a dose of 100 mg BID under close supervision for rhythm control was administered. Also, anticoagulation with edoxaban was provided. The patient remained asymptomatic until ablation was performed. Pulmonary vein isolation with pulsed field ablation and cavotricuspid isthmus ablation was performed 10 days after ambulatory ECG monitoring. There were no paroxysms of atrial fibrillation after ablation. Antiarrhythmic agents in patients with conversion pauses may worsen sinus node function but may also eliminate atrial fibrillation paroxysms preventing conversion pauses. Thus, catheter ablation may be an option for a patient presenting with atrial fibrillation and conversion pauses to avoid unnecessary permanent pacemaker implantation. Short-term pharmacological bridging with flecainide under close supervision may be used in patients with atrial fibrillation and conversion pauses without other signs of sinus node dysfunction, providing effective rhythm control.
- 1 July 2026
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 19, 1-6
Open AccessTemporary Rhythm Control with Flecainide in Atrial Fibrillation-Related Conversion Pauses Prior to Catheter Ablation: A Case of Successful Pharmacological Bridging
The management of paroxysmal atrial fibrillation with conversion pauses remains challenging, with catheter ablation and permanent pacemaker implantation representing the main therapeutic strategies. Catheter ablation may eliminate atrial fibrillation paroxysms and prevent conversion pauses, whereas pacemaker implantation combined with antiarrhythmic therapy for rhythm control is another accepted option. We report a case of successful management of paroxysmal atrial fibrillation with conversion pauses using antiarrhythmic agents for rhythm control prior to catheter ablation. A 61-year-old woman had episodes of palpitations, dizziness, and presyncope. Ambulatory 12-lead 24-hour ECG monitoring showed 51 episodes of atrial fibrillation and atrial flutter with conversion pauses after each of them; the longest pause was 7460 ms. Atrial fibrillation lasted for 46.9% of the total monitoring time. When ambulatory 24-hour monitoring was performed, the patient was highly symptomatic (complaints of palpitations and fear of death were predominant, but dizziness episodes were also noted). Catheter ablation was unavailable in the short-term period and permanent pacemaker implantation was not accepted by the patient. Thus, flecainide at a dose of 100 mg BID under close supervision for rhythm control was administered. Also, anticoagulation with edoxaban was provided. The patient remained asymptomatic until ablation was performed. Pulmonary vein isolation with pulsed field ablation and cavotricuspid isthmus ablation was performed 10 days after ambulatory ECG monitoring. There were no paroxysms of atrial fibrillation after ablation. Antiarrhythmic agents in patients with conversion pauses may worsen sinus node function but may also eliminate atrial fibrillation paroxysms preventing conversion pauses. Thus, catheter ablation may be an option for a patient presenting with atrial fibrillation and conversion pauses to avoid unnecessary permanent pacemaker implantation. Short-term pharmacological bridging with flecainide under close supervision may be used in patients with atrial fibrillation and conversion pauses without other signs of sinus node dysfunction, providing effective rhythm control.
- Open Access
- 2 January 2026
- Published by Charles University in Prague, Karolinum Press in Prague Medical Report
- Vol. 126 (4) , 201-206
Impact of Age and Gender on Mean QT and QTc Intervals Measured with Ambulatory Electrocardiogram Monitoring
Although the impact of age and gender on QT and QTc intervals on conventional electrocardiogram (ECG) has been well studied, the impact of these factors on mean QT and QTc intervals measured with ambulatory ECG monitoring has not been studied. The aim of this study was to assess the impact of age and gender on mean QT and QTc intervals measured with ambulatory ECG monitoring. Recordings of ambulatory ECG monitoring from 380 patients without significant cardiac abnormalities were analysed. The mean QT interval was longer in women (390.5 [373.0–405.0] ms) than in men (380.0 [366.0–397.5] ms) (p<0.001). The mean QTc interval was also longer in women (439.0 [429.0–447.5] ms) than in men (428.5 [417.0–441.0] ms) (p<0.001). The normal (2.5–97.5 percentiles) mean QTc interval measured with ambulatory ECG monitoring ranged from 393 to 466 ms in men and from 411 to 471 ms in women. QT and QTc intervals increased with age (p<0.001). There was a positive correlation between age and QT interval (r=0.474, p<0.001) as well as between age and QTc interval (r=0.263, p<0.001). Thus, female gender is associated with longer mean QT and QTc intervals measured with ambulatory ECG monitoring. QT and QTc intervals become longer with age.
- 2 January 2026
- Published by Charles University in Prague, Karolinum Press in Prague Medical Report
- Vol. 126 (4) , 201-206
Open AccessImpact of Age and Gender on Mean QT and QTc Intervals Measured with Ambulatory Electrocardiogram Monitoring
Although the impact of age and gender on QT and QTc intervals on conventional electrocardiogram (ECG) has been well studied, the impact of these factors on mean QT and QTc intervals measured with ambulatory ECG monitoring has not been studied. The aim of this study was to assess the impact of age and gender on mean QT and QTc intervals measured with ambulatory ECG monitoring. Recordings of ambulatory ECG monitoring from 380 patients without significant cardiac abnormalities were analysed. The mean QT interval was longer in women (390.5 [373.0–405.0] ms) than in men (380.0 [366.0–397.5] ms) (p<0.001). The mean QTc interval was also longer in women (439.0 [429.0–447.5] ms) than in men (428.5 [417.0–441.0] ms) (p<0.001). The normal (2.5–97.5 percentiles) mean QTc interval measured with ambulatory ECG monitoring ranged from 393 to 466 ms in men and from 411 to 471 ms in women. QT and QTc intervals increased with age (p<0.001). There was a positive correlation between age and QT interval (r=0.474, p<0.001) as well as between age and QTc interval (r=0.263, p<0.001). Thus, female gender is associated with longer mean QT and QTc intervals measured with ambulatory ECG monitoring. QT and QTc intervals become longer with age.
- Open Access
- 1 November 2025
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 18, 1457-1464
Blocked Atrial Bigeminy as an Unusual Cause of Bradycardia: A Case Report
The diagnosis of blocked atrial bigeminy may be challenging. It can easily be misinterpreted as sinus bradycardia or sinus exit block leading to unnecessary pacemaker implantation. We report a case of frequent blocked premature atrial contractions leading to episodes of marked bradycardia. A 66-year-old man disturbed with low pulse (42 bpm) measured by an automated blood pressure monitor sought medical attention. The patient also had untreated grade I arterial hypertension. Ambulatory ECG monitoring was performed and very frequent blocked premature atrial contractions were seen. The P wave of the atrial premature atrial contractions was always superimposed on the ST segment or T wave simulating a bifid T wave. Blocked atrial quadrigeminy, blocked atrial trigeminy, and blocked atrial bigeminy were observed. The minimum heart rate associated with blocked atrial bigeminy was 37 bpm. There were multiple episodes of regular ventricular rhythm during blocked atrial bigeminy. NT-proBNP concentration was within normal limits. Echocardiography showed only mild left ventricular hypertrophy, mild left atrial dilation and type I diastolic dysfunction. Therapy with flecainide and amiodarone separately was not effective. Option of radiofrequency catheter ablation was discussed with the patient, but was not accepted due to procedural risks and absence of severe symptoms related to blocked PACs. The patient was reassured and regular follow-up was recommended. The target values of blood pressure were achieved with candesartan at a dose of 32 mg. Thus, blocked atrial bigeminy is a rare cause of bradycardia with a regular ventricular rhythm. Recognition of the P wave superimposed on the ST segment or the T wave may be a clue for a correct diagnosis. Physicians should be aware of this condition to avoid unnecessary pacemaker implantation.
- 1 November 2025
- Published by Taylor & Francis in International Medical Case Reports Journal
- Vol. ume 18, 1457-1464
Open AccessBlocked Atrial Bigeminy as an Unusual Cause of Bradycardia: A Case Report
The diagnosis of blocked atrial bigeminy may be challenging. It can easily be misinterpreted as sinus bradycardia or sinus exit block leading to unnecessary pacemaker implantation. We report a case of frequent blocked premature atrial contractions leading to episodes of marked bradycardia. A 66-year-old man disturbed with low pulse (42 bpm) measured by an automated blood pressure monitor sought medical attention. The patient also had untreated grade I arterial hypertension. Ambulatory ECG monitoring was performed and very frequent blocked premature atrial contractions were seen. The P wave of the atrial premature atrial contractions was always superimposed on the ST segment or T wave simulating a bifid T wave. Blocked atrial quadrigeminy, blocked atrial trigeminy, and blocked atrial bigeminy were observed. The minimum heart rate associated with blocked atrial bigeminy was 37 bpm. There were multiple episodes of regular ventricular rhythm during blocked atrial bigeminy. NT-proBNP concentration was within normal limits. Echocardiography showed only mild left ventricular hypertrophy, mild left atrial dilation and type I diastolic dysfunction. Therapy with flecainide and amiodarone separately was not effective. Option of radiofrequency catheter ablation was discussed with the patient, but was not accepted due to procedural risks and absence of severe symptoms related to blocked PACs. The patient was reassured and regular follow-up was recommended. The target values of blood pressure were achieved with candesartan at a dose of 32 mg. Thus, blocked atrial bigeminy is a rare cause of bradycardia with a regular ventricular rhythm. Recognition of the P wave superimposed on the ST segment or the T wave may be a clue for a correct diagnosis. Physicians should be aware of this condition to avoid unnecessary pacemaker implantation.
- Open Access
- 1 September 2025
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 38 (9) , 597-598
Atrial Fibrillation Patterns on Ambulatory Electrocardiogram Monitoring and Risk of Stroke
- 1 September 2025
- Published by Ordem dos Medicos in Acta Medica Portuguesa
- Vol. 38 (9) , 597-598
Open AccessAtrial Fibrillation Patterns on Ambulatory Electrocardiogram Monitoring and Risk of Stroke
- Open Access
- 10 December 2023
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 10-16
sST 2 AS A MARKER OF THE TREATMENT OF PATIENTS AFTER MYOCARDIAL INFARCTION WITH ACCOMPANYING ARTERIAL HYPERTENSION ON THE BACKGROUND OF TREATMENT WITH MELDONIUM AND FOLIC ACID
Ішемічна хвороба серця (ІХС) є однією з основних причин смертності в Україні та в усьому світі. Артеріальна гіпертензія (АГ) є найбільш поширеним керованим фактором серцево-судинної захворюваності. sST2 — це сучасний маркер кардіофіброзу, який може допомогти оцінити ефективність основного лікування пацієнтів з ІХС та супутньою АГ. Мета. Вивчити можливість застосування sST2 як маркера ефективності лікування пацієнтів після перенесеного інфаркту міокарда із супутньою артеріальною гіпертензією на фоні лікування мельдонієм і фолієвою кислотою. Матеріали та методи. Обстежено 40 пацієнтів із СІХС ФК ІІ-ІІІ та супутньою АГ ІІІ стадії після гострого інфаркту міокарда та ургентного стентування. Хворих було поділено на 2 групи по 20 пацієнтів: ті, які отримували стандартне лікування, і ті, які, окрім стандартного лікування, отримували комбінацію фолієвої кислоти і мельдонію. У процесі дослідження ми провели аналіз результатів загальноклінічних, лабораторних та інструментальних методів обстеження. Лабораторне дослідження рівнів sST2 у плазмі крові проводили шляхом кількісного імуноферментного аналізу. Показники серцевої гемодинаміки визначали методом ЕхоКГ. Результати. Спостерігалося покращення всіх показників ЕхоКГ у пацієнтів обох груп. Більш суттєві зміни зафіксовано стосовно КСР лівого шлуночка. Також спостерігалася інша тенденція щодо динаміки товщини задньої стінки ЛШ у систолу. У 1-й групі зниження цього показника становило 5,7% (p>0,05), а в 2-й групі ‑ 26,9% (pВисновки. Встановлено доцільність використання sST2 як маркера ефективності лікування хворих після інфаркту міокарда із супутньою АГ на фоні лікування мельдонієм і фолієвою кислотою. Застосування цитопротекторів достовірно знижувало концентрацію sST2, що робить доцільним їх використання у комплексному лікуванні хворих після перенесеного ІМ із супутньою АГ.
- 10 December 2023
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 10-16
Open AccesssST 2 AS A MARKER OF THE TREATMENT OF PATIENTS AFTER MYOCARDIAL INFARCTION WITH ACCOMPANYING ARTERIAL HYPERTENSION ON THE BACKGROUND OF TREATMENT WITH MELDONIUM AND FOLIC ACID
Ішемічна хвороба серця (ІХС) є однією з основних причин смертності в Україні та в усьому світі. Артеріальна гіпертензія (АГ) є найбільш поширеним керованим фактором серцево-судинної захворюваності. sST2 — це сучасний маркер кардіофіброзу, який може допомогти оцінити ефективність основного лікування пацієнтів з ІХС та супутньою АГ. Мета. Вивчити можливість застосування sST2 як маркера ефективності лікування пацієнтів після перенесеного інфаркту міокарда із супутньою артеріальною гіпертензією на фоні лікування мельдонієм і фолієвою кислотою. Матеріали та методи. Обстежено 40 пацієнтів із СІХС ФК ІІ-ІІІ та супутньою АГ ІІІ стадії після гострого інфаркту міокарда та ургентного стентування. Хворих було поділено на 2 групи по 20 пацієнтів: ті, які отримували стандартне лікування, і ті, які, окрім стандартного лікування, отримували комбінацію фолієвої кислоти і мельдонію. У процесі дослідження ми провели аналіз результатів загальноклінічних, лабораторних та інструментальних методів обстеження. Лабораторне дослідження рівнів sST2 у плазмі крові проводили шляхом кількісного імуноферментного аналізу. Показники серцевої гемодинаміки визначали методом ЕхоКГ. Результати. Спостерігалося покращення всіх показників ЕхоКГ у пацієнтів обох груп. Більш суттєві зміни зафіксовано стосовно КСР лівого шлуночка. Також спостерігалася інша тенденція щодо динаміки товщини задньої стінки ЛШ у систолу. У 1-й групі зниження цього показника становило 5,7% (p>0,05), а в 2-й групі ‑ 26,9% (pВисновки. Встановлено доцільність використання sST2 як маркера ефективності лікування хворих після інфаркту міокарда із супутньою АГ на фоні лікування мельдонієм і фолієвою кислотою. Застосування цитопротекторів достовірно знижувало концентрацію sST2, що робить доцільним їх використання у комплексному лікуванні хворих після перенесеного ІМ із супутньою АГ.
- Open Access
- 10 December 2023
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 134-138
EXPERIENCE OF USING THE ORAL FORM OF ADENOSINE IN PATIENTS WITH UNSTABLE ANGINA
Серцево-судинні захворювання залишаються глобальною загрозою для здоров’я, а стенокардія є найпоширенішим їхнім симптомом. Нестабільна стенокардія постає одним із клінічних варіантів гострого коронарного синдрому. Мета. Оцінити ефективність і безпечність застосування АТФ-вмісного препарату Ангелон у пацієнтів із дестабілізацією ішемічної хвороби серця – нестабільною стенокардією. Матеріали та методи. Когорта дослідження складалася з 59 пацієнтів із діагнозом «нестабільна стенокардія», яких було госпіталізовано у відділення Інфаркту міокарда Комунального некомерційного підприємства «Івано-Франківський обласний клінічний кардіологічний центр» Івано-Франківської обласної ради в період з березня по жовтень 2023 року. Хворих поділено на дві окремі групи залежно від призначеного лікування: пацієнти 1-ї групи (n=30) отримували винятково стандартне лікування, пацієнти 2-ї (n=29) одержували додатково до базової терапії препарат Ангелон упродовж 10 днів у дозі 80 мг 1 раз на добу. Результати. Одним із помітних результатів постає зниження тяжкості стенокардії після лікування Ангелоном, яке було статистично значущим. Таке зменшення симптомів стенокардії може суттєво вплинути на якість життя пацієнтів і знизити їхній серцево-судинний ризик. Тим паче, поліпшення фракції викиду (ФВ) лівого шлуночка є критичним показником покращення серцевої функції, що має важливе значення для пацієнтів із НС. Достовірно краще виконання 6-ти хвилинного тесту в групі Ангелону є ще одним переконливим свідченням його ефективності. Висновки. Лікування за допомогою Ангелону асоціюється з позитивними результатами, зокрема при цьому зменшення тяжкості стенокардії, збільшення фракції викиду лівого шлуночка та покращення толерантості до фізичного навантаження. Ці відомості свідчать про те, що Ангелон є перспективним засобом лікування пацієнтів із нестабільною стенокардією. Власне, на думку лікарів, цей препарат, так би мовити, пропонує потенційний шлях до полегшення симптомів і покращення здоров’я серця.
- 10 December 2023
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 134-138
Open AccessEXPERIENCE OF USING THE ORAL FORM OF ADENOSINE IN PATIENTS WITH UNSTABLE ANGINA
Серцево-судинні захворювання залишаються глобальною загрозою для здоров’я, а стенокардія є найпоширенішим їхнім симптомом. Нестабільна стенокардія постає одним із клінічних варіантів гострого коронарного синдрому. Мета. Оцінити ефективність і безпечність застосування АТФ-вмісного препарату Ангелон у пацієнтів із дестабілізацією ішемічної хвороби серця – нестабільною стенокардією. Матеріали та методи. Когорта дослідження складалася з 59 пацієнтів із діагнозом «нестабільна стенокардія», яких було госпіталізовано у відділення Інфаркту міокарда Комунального некомерційного підприємства «Івано-Франківський обласний клінічний кардіологічний центр» Івано-Франківської обласної ради в період з березня по жовтень 2023 року. Хворих поділено на дві окремі групи залежно від призначеного лікування: пацієнти 1-ї групи (n=30) отримували винятково стандартне лікування, пацієнти 2-ї (n=29) одержували додатково до базової терапії препарат Ангелон упродовж 10 днів у дозі 80 мг 1 раз на добу. Результати. Одним із помітних результатів постає зниження тяжкості стенокардії після лікування Ангелоном, яке було статистично значущим. Таке зменшення симптомів стенокардії може суттєво вплинути на якість життя пацієнтів і знизити їхній серцево-судинний ризик. Тим паче, поліпшення фракції викиду (ФВ) лівого шлуночка є критичним показником покращення серцевої функції, що має важливе значення для пацієнтів із НС. Достовірно краще виконання 6-ти хвилинного тесту в групі Ангелону є ще одним переконливим свідченням його ефективності. Висновки. Лікування за допомогою Ангелону асоціюється з позитивними результатами, зокрема при цьому зменшення тяжкості стенокардії, збільшення фракції викиду лівого шлуночка та покращення толерантості до фізичного навантаження. Ці відомості свідчать про те, що Ангелон є перспективним засобом лікування пацієнтів із нестабільною стенокардією. Власне, на думку лікарів, цей препарат, так би мовити, пропонує потенційний шлях до полегшення симптомів і покращення здоров’я серця.
- Open Access
- 12 April 2023
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 66-70
PECULIARITIES OF CONNECTIVE TISSUE METABOLISM IN PATIENTS WITH POST-INFARCTION REMODELING AND REPERFUSION SYNDROME
Early restoration of coronary blood flow in acute myocardial infarction with elevation helps reduce the area of myocardial necrosis, prevent dilatation of the ventricular cavity, and reduce the development of arrhythmias and mortality. However, despite modern technologies in STEMI treatment, the development of reperfusion syndrome, in particular, arrhythmias, is possible after the restoration of blood flow in the infarct-related artery, which is a consequence of acute cellular, metabolic and local electrophysiological changes in the myocardium. The aim: is to investigate the long-term effects of reperfusion syndrome on the catabolic/anabolic activity of connective tissue and the processes of connective tissue framework formation in the post-infarction period in patients with myocardial infarction. Materials and methods. The study involved 156 patients with acute myocardial infarction with ST segment elevation (STEMI), and 15 apparently healthy individuals (control of laboratory parameters). The average age of the patients was (57.8±1.2) years. The percent of male patients prevailed (76 %). All MI patients were divided into two groups: Group I (98 people) – MI patients without clinical signs of reperfusion syndrome during revascularization, Group II (58 people) – MI patients with the signs of reperfusion syndrome in the form of rhythm and conductivity disturbances during revascularization of coronary arteries by percutaneous coronarography intervention (PCI) with prolonged stenting of the infarct-dependent coronary artery. Peculiarities of connective tissue metabolism were studied by the content of free and bound oxyproline, glycosaminoglycans, and antibodies to atypical collagens (Ig M and Ig G) in blood serum. Results. The recovery period after myocardial infarction showed an increase in collagen catabolism over collagen synthesizing processes in patients with MI who had reperfusion syndrome. The described patterns were also established by changes in glycosaminoglycans. The study showed an increase in the level of antibodies to atypical collagens. Particularly, the level of Ig M, which was within the norm (0.43±0.18) ng/ml, in patients with MI without reperfusion manifestations was three times higher (p<0.001), and in cases of combination of MI and reperfusion syndrome – the highest (p<0.001). Conclusions: Changes in collagen-synthesizing processes are observed in patients with MI, with a tendency to increase the processes of catabolism of the connective tissue matrix. The presence of reperfusion syndrome manifestations in MI patients after revascularization aggravates the processes of catabolism, even in the recovery period after MI. Increase in the activity of catabolic processes stimulates fibrosis and formation of rigid matrix and atypical collagen, to which antibodies are synthesized, thus blocking the pathological circuit of restructuring of the heart connective tissue framework, and accordingly its pathological remodeling. The obtained study results contribute to the identification of more sophisticated approaches to revascularization techniques to avoid negative effects of reperfusion syndrome, as well as new effective medications for collagen synthesis correction, which can increase the effectiveness of rehabilitative management of such Early restoration of coronary blood flow in acute myocardial infarction with elevation helps reduce the area of myocardial necrosis, prevent dilatation of the ventricular cavity, and reduce the development of arrhythmias and mortality. However, despite modern technologies in STEMI treatment, the development of reperfusion syndrome, in particular, arrhythmias, is possible after the restoration of blood flow in the infarct-related artery, which is a consequence of acute cellular, metabolic and local electrophysiological changes in the myocardium. The aim: is to investigate the long-term effects of reperfusion syndrome on the catabolic/anabolic activity of connective tissue and the processes of connective tissue framework formation in the post-infarction period in patients with myocardial infarction. Materials and methods. The study involved 156 patients with acute myocardial infarction with ST segment elevation (STEMI), and 15 apparently healthy individuals (control of laboratory parameters). The average age of the patients was (57.8±1.2) years. The percent of male patients prevailed (76 %). All MI patients were divided into two groups: Group I (98 people) – MI patients without clinical signs of reperfusion syndrome during revascularization, Group II (58 people) – MI patients with the signs of reperfusion syndrome in the form of rhythm and conductivity disturbances during revascularization of coronary arteries by percutaneous coronarography intervention (PCI) with prolonged stenting of the infarct-dependent coronary artery. Peculiarities of connective tissue metabolism were studied by the content of free and bound oxyproline, glycosaminoglycans, and antibodies to atypical collagens (Ig M and Ig G) in blood serum. Results. The recovery period after myocardial infarction showed an increase in collagen catabolism over collagen synthesizing processes in patients with MI who had reperfusion syndrome. The described patterns were also established by changes in glycosaminoglycans. The study showed an increase in the level of antibodies to atypical collagens. Particularly, the level of Ig M, which was within the norm (0.43±0.18) ng/ml, in patients with MI without reperfusion manifestations was three times higher (p<0.001), and in cases of combination of MI and reperfusion syndrome – the highest (p<0.001). Conclusions: Changes in collagen-synthesizing processes are observed in patients with MI, with a tendency to increase the processes of catabolism of the connective tissue matrix. The presence of reperfusion syndrome manifestations in MI patients after revascularization aggravates the...
- 12 April 2023
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 66-70
Open AccessPECULIARITIES OF CONNECTIVE TISSUE METABOLISM IN PATIENTS WITH POST-INFARCTION REMODELING AND REPERFUSION SYNDROME
Early restoration of coronary blood flow in acute myocardial infarction with elevation helps reduce the area of myocardial necrosis, prevent dilatation of the ventricular cavity, and reduce the development of arrhythmias and mortality. However, despite modern technologies in STEMI treatment, the development of reperfusion syndrome, in particular, arrhythmias, is possible after the restoration of blood flow in the infarct-related artery, which is a consequence of acute cellular, metabolic and local electrophysiological changes in the myocardium. The aim: is to investigate the long-term effects of reperfusion syndrome on the catabolic/anabolic activity of connective tissue and the processes of connective tissue framework formation in the post-infarction period in patients with myocardial infarction. Materials and methods. The study involved 156 patients with acute myocardial infarction with ST segment elevation (STEMI), and 15 apparently healthy individuals (control of laboratory parameters). The average age of the patients was (57.8±1.2) years. The percent of male patients prevailed (76 %). All MI patients were divided into two groups: Group I (98 people) – MI patients without clinical signs of reperfusion syndrome during revascularization, Group II (58 people) – MI patients with the signs of reperfusion syndrome in the form of rhythm and conductivity disturbances during revascularization of coronary arteries by percutaneous coronarography intervention (PCI) with prolonged stenting of the infarct-dependent coronary artery. Peculiarities of connective tissue metabolism were studied by the content of free and bound oxyproline, glycosaminoglycans, and antibodies to atypical collagens (Ig M and Ig G) in blood serum. Results. The recovery period after myocardial infarction showed an increase in collagen catabolism over collagen synthesizing processes in patients with MI who had reperfusion syndrome. The described patterns were also established by changes in glycosaminoglycans. The study showed an increase in the level of antibodies to atypical collagens. Particularly, the level of Ig M, which was within the norm (0.43±0.18) ng/ml, in patients with MI without reperfusion manifestations was three times higher (p<0.001), and in cases of combination of MI and reperfusion syndrome – the highest (p<0.001). Conclusions: Changes in collagen-synthesizing processes are observed in patients with MI, with a tendency to increase the processes of catabolism of the connective tissue matrix. The presence of reperfusion syndrome manifestations in MI patients after revascularization aggravates the processes of catabolism, even in the recovery period after MI. Increase in the activity of catabolic processes stimulates fibrosis and formation of rigid matrix and atypical collagen, to which antibodies are synthesized, thus blocking the pathological circuit of restructuring of the heart connective tissue framework, and accordingly its pathological remodeling. The obtained study results contribute to the identification of more sophisticated approaches to revascularization techniques to avoid negative effects of reperfusion syndrome, as well as new effective medications for collagen synthesis correction, which can increase the effectiveness of rehabilitative management of such Early restoration of coronary blood flow in acute myocardial infarction with elevation helps reduce the area of myocardial necrosis, prevent dilatation of the ventricular cavity, and reduce the development of arrhythmias and mortality. However, despite modern technologies in STEMI treatment, the development of reperfusion syndrome, in particular, arrhythmias, is possible after the restoration of blood flow in the infarct-related artery, which is a consequence of acute cellular, metabolic and local electrophysiological changes in the myocardium. The aim: is to investigate the long-term effects of reperfusion syndrome on the catabolic/anabolic activity of connective tissue and the processes of connective tissue framework formation in the post-infarction period in patients with myocardial infarction. Materials and methods. The study involved 156 patients with acute myocardial infarction with ST segment elevation (STEMI), and 15 apparently healthy individuals (control of laboratory parameters). The average age of the patients was (57.8±1.2) years. The percent of male patients prevailed (76 %). All MI patients were divided into two groups: Group I (98 people) – MI patients without clinical signs of reperfusion syndrome during revascularization, Group II (58 people) – MI patients with the signs of reperfusion syndrome in the form of rhythm and conductivity disturbances during revascularization of coronary arteries by percutaneous coronarography intervention (PCI) with prolonged stenting of the infarct-dependent coronary artery. Peculiarities of connective tissue metabolism were studied by the content of free and bound oxyproline, glycosaminoglycans, and antibodies to atypical collagens (Ig M and Ig G) in blood serum. Results. The recovery period after myocardial infarction showed an increase in collagen catabolism over collagen synthesizing processes in patients with MI who had reperfusion syndrome. The described patterns were also established by changes in glycosaminoglycans. The study showed an increase in the level of antibodies to atypical collagens. Particularly, the level of Ig M, which was within the norm (0.43±0.18) ng/ml, in patients with MI without reperfusion manifestations was three times higher (p<0.001), and in cases of combination of MI and reperfusion syndrome – the highest (p<0.001). Conclusions: Changes in collagen-synthesizing processes are observed in patients with MI, with a tendency to increase the processes of catabolism of the connective tissue matrix. The presence of reperfusion syndrome manifestations in MI patients after revascularization aggravates the...
- Open Access
- 21 May 2022
- Published by LLC Publishing house Medknyha in Терапевтика
- Vol. 3 (1) , 5-12
Ятрогенна перфорація коронарної артерії з успішною реканалізацією як ускладнення черезшкірного коронарного втручання
In given clinical case our goals is to review treatment tactics of iatrogenic complication after percutaneous coronary intervention, which was used for treating ischemic heart disease. The most interest lies in aspects of emergency care and drug-assisted treatment with iatrogenic coronal artery perforation. This case caries great interest not only for interventional cardiologists but also for regular cardiology specialists and family medicine doctors, given case shows outmost importance of treating patients with post percutaneous coronary intervention complications as such with perforation of coronal artery. Inferences made from this clinical case can be used in medical practice. У представленому клінічному випадку розглядається тактика ведення пацієнтів з ятрогенними ускладненнями черезшкірного коронарного втручання з приводу обструктивної ішемічної хвороби серця. Акцентовано увагу на особливостях невідкладної допомоги та медикаментозного лікування пацієнтів з ятрогенною перфорацією коронарної артерії. Випадок цікавий не лише для спеціалістів інтервенційної кардіології, але й для кардіологів-терапевтів та сімейних лікарів, оскільки менеджмент пацієнтів з ускладненнями після черезшкірних коронарних втручань, зокрема після перфорації коронарної артерії, заслуговує особливої уваги. Висновки з клінічного розбору даного випадку можуть бути корисними для реальної медичної практики.
- 21 May 2022
- Published by LLC Publishing house Medknyha in Терапевтика
- Vol. 3 (1) , 5-12
Open AccessЯтрогенна перфорація коронарної артерії з успішною реканалізацією як ускладнення черезшкірного коронарного втручання
In given clinical case our goals is to review treatment tactics of iatrogenic complication after percutaneous coronary intervention, which was used for treating ischemic heart disease. The most interest lies in aspects of emergency care and drug-assisted treatment with iatrogenic coronal artery perforation. This case caries great interest not only for interventional cardiologists but also for regular cardiology specialists and family medicine doctors, given case shows outmost importance of treating patients with post percutaneous coronary intervention complications as such with perforation of coronal artery. Inferences made from this clinical case can be used in medical practice. У представленому клінічному випадку розглядається тактика ведення пацієнтів з ятрогенними ускладненнями черезшкірного коронарного втручання з приводу обструктивної ішемічної хвороби серця. Акцентовано увагу на особливостях невідкладної допомоги та медикаментозного лікування пацієнтів з ятрогенною перфорацією коронарної артерії. Випадок цікавий не лише для спеціалістів інтервенційної кардіології, але й для кардіологів-терапевтів та сімейних лікарів, оскільки менеджмент пацієнтів з ускладненнями після черезшкірних коронарних втручань, зокрема після перфорації коронарної артерії, заслуговує особливої уваги. Висновки з клінічного розбору даного випадку можуть бути корисними для реальної медичної практики.
- Open Access
- 11 April 2022
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 161-168
PANDORA`S BOX OR «NO-REFLOW» PHENOMENON (CLINICAL CASE)
It has been established that successful repefusion of ocluded infarct-dependent coronary artery (IDCA) during percutaneous coronary intervention does not mean restoration of myocardial perfusion. This «no-reflow» phenomenon is known from the studies of R. Kloner, C. Ganote, R. Jennings (1974). They were among the first to note only a partial restoration of coronary blood flow after the reperfusion of mechanically occluded for 90-180 minutes coronary artery in dogs. The authors considered damage to the capillary endothelium, edema of the damaged wall and extravasal tissues, and protrusion into the capillary cavity to be the cause of this phenomenon. The frequency of the phenomenon of «no-reflow» after the successful restoration of coronary blood flow in the IDCA varies between 5 - 40% of all cases. The development of this phenomenon was an unfavorable prognostic factor, primarily in terms of mortality and deterioration of the functional state of the left ventricle. The pathophysiology of the «no-reflow» phenomenon remains poorly understood. Obviously, it has a multifactorial nature and cannot be described by any one mechanism. Analyzing the phenomenon of «no-reflow», it is noted that in spite of the reperfusion of IDCA, there are pronounced pathophysiological changes in the microcirculatory tract, the essence of which is to block myocardial perfusion in the area of myocardial infarction. During the COVID-19 pandemic, the number of patients with myocardial infarction increased, including an increase in the number of diagnosed «no-reflow» and «slow-flow» phenomena, which is associated with the impact of SARS СOVID-19 virus on the myocardium, namely the development of microvascular damage. There is currently no specific therapy for the prevention and treatment of «no-reflow» phenomen that would be recommended for patients with STEMI. This article presents a clinical case of the phenomenon of «no-reflow» in patient B., 56 years old, who complained of severe chest pain, irradiation in the left shoulder and lower jaw, shortness of breath, general weakness. History of hypertension, coronavirus PCR +. Troponin I - 5.4 ng/ml. According to the electrocardiogram: elevation of the ST segment in II. III, aVF leads. At the time of contrast infusion during stenting of infarct-dependent right coronary artery, its slow filling was recorded - the phenomenon of «no-reflow» TIMI 0, MBG-0. The patient was discharged from the hospital in satisfactory condition under the supervision of a family doctor. Conclusions: The phenomenon of «no-reflow» is a topical and unresolved issue of myocardial revascularization in real clinical practice. The most common prerequisite for the development of the phenomenon of «no-reflow» after myocardial revascularization is late hospitalization, and aggravating circumstances - comorbid pathology (COVID-19, hypertension, diabetes). This clinical case is interesting because the patient with lesions of the lower left ventricular wall PCI was complicated by the phenomenon of «no-reflow», as evidenced by the slowing of ST segment resolution, lack of myocardial perfusion, parietal thrombosis throughout the RCA. Further search for ways to prevent and treat irreversible blood flow syndrome after successful reperfusion of infarct-dependent coronary artery is needed. It has been established that successful repefusion of ocluded infarct-dependent coronary artery (IDCA) during percutaneous coronary intervention does not mean restoration of myocardial perfusion. This «no-reflow» phenomenon is known from the studies of R. Kloner, C. Ganote, R. Jennings (1974). They were among the first to note only a partial restoration of coronary blood flow after the reperfusion of mechanically occluded for 90-180 minutes coronary artery in dogs. The authors considered damage to the capillary endothelium, edema of the damaged wall and extravasal tissues, and protrusion into the capillary cavity to be the cause of this phenomenon. The frequency of the phenomenon of «no-reflow» after the successful restoration of coronary blood flow in the IDCA varies between 5 - 40% of all cases. The development of this phenomenon was an unfavorable prognostic factor, primarily in terms of mortality and deterioration of the functional state of the left ventricle. The pathophysiology of the «no-reflow» phenomenon remains poorly understood. Obviously, it has a multifactorial nature and cannot be described by any one mechanism. Analyzing the phenomenon of «no-reflow», it is noted that in spite of the reperfusion of IDCA, there are pronounced pathophysiological changes in the microcirculatory tract, the essence of which is to block myocardial perfusion in the area of myocardial infarction. During the COVID-19 pandemic, the number of patients with myocardial infarction increased, including an increase in the number of diagnosed «no-reflow» and «slow-flow» phenomena, which is associated with the impact of SARS СOVID-19 virus on the myocardium, namely the development of microvascular damage. There is currently no specific therapy for the prevention and treatment of «no-reflow» phenomen that would be recommended for patients with STEMI. This article presents a clinical case of the phenomenon of «no-reflow» in patient B., 56 years old, who complained of severe chest pain, irradiation in the left shoulder and lower jaw, shortness of breath, general weakness. History of hypertension, coronavirus PCR +. Troponin I - 5.4 ng/ml. According to the electrocardiogram: elevation of the ST segment in II. III, aVF leads. At the time of contrast infusion during stenting of infarct-dependent right coronary artery, its slow filling was recorded - the phenomenon of «no-reflow» TIMI 0, MBG-0. The patient was discharged from the hospital in satisfactory condition under the supervision of a family doctor. Conclusions: The phenomenon of «no-reflow» is a topical and unresolved issue of myocardial...
- 11 April 2022
- Published by Ivano-Frankivsk National Medical University in Art of Medicine
- p. 161-168
Open AccessPANDORA`S BOX OR «NO-REFLOW» PHENOMENON (CLINICAL CASE)
It has been established that successful repefusion of ocluded infarct-dependent coronary artery (IDCA) during percutaneous coronary intervention does not mean restoration of myocardial perfusion. This «no-reflow» phenomenon is known from the studies of R. Kloner, C. Ganote, R. Jennings (1974). They were among the first to note only a partial restoration of coronary blood flow after the reperfusion of mechanically occluded for 90-180 minutes coronary artery in dogs. The authors considered damage to the capillary endothelium, edema of the damaged wall and extravasal tissues, and protrusion into the capillary cavity to be the cause of this phenomenon. The frequency of the phenomenon of «no-reflow» after the successful restoration of coronary blood flow in the IDCA varies between 5 - 40% of all cases. The development of this phenomenon was an unfavorable prognostic factor, primarily in terms of mortality and deterioration of the functional state of the left ventricle. The pathophysiology of the «no-reflow» phenomenon remains poorly understood. Obviously, it has a multifactorial nature and cannot be described by any one mechanism. Analyzing the phenomenon of «no-reflow», it is noted that in spite of the reperfusion of IDCA, there are pronounced pathophysiological changes in the microcirculatory tract, the essence of which is to block myocardial perfusion in the area of myocardial infarction. During the COVID-19 pandemic, the number of patients with myocardial infarction increased, including an increase in the number of diagnosed «no-reflow» and «slow-flow» phenomena, which is associated with the impact of SARS СOVID-19 virus on the myocardium, namely the development of microvascular damage. There is currently no specific therapy for the prevention and treatment of «no-reflow» phenomen that would be recommended for patients with STEMI. This article presents a clinical case of the phenomenon of «no-reflow» in patient B., 56 years old, who complained of severe chest pain, irradiation in the left shoulder and lower jaw, shortness of breath, general weakness. History of hypertension, coronavirus PCR +. Troponin I - 5.4 ng/ml. According to the electrocardiogram: elevation of the ST segment in II. III, aVF leads. At the time of contrast infusion during stenting of infarct-dependent right coronary artery, its slow filling was recorded - the phenomenon of «no-reflow» TIMI 0, MBG-0. The patient was discharged from the hospital in satisfactory condition under the supervision of a family doctor. Conclusions: The phenomenon of «no-reflow» is a topical and unresolved issue of myocardial revascularization in real clinical practice. The most common prerequisite for the development of the phenomenon of «no-reflow» after myocardial revascularization is late hospitalization, and aggravating circumstances - comorbid pathology (COVID-19, hypertension, diabetes). This clinical case is interesting because the patient with lesions of the lower left ventricular wall PCI was complicated by the phenomenon of «no-reflow», as evidenced by the slowing of ST segment resolution, lack of myocardial perfusion, parietal thrombosis throughout the RCA. Further search for ways to prevent and treat irreversible blood flow syndrome after successful reperfusion of infarct-dependent coronary artery is needed. It has been established that successful repefusion of ocluded infarct-dependent coronary artery (IDCA) during percutaneous coronary intervention does not mean restoration of myocardial perfusion. This «no-reflow» phenomenon is known from the studies of R. Kloner, C. Ganote, R. Jennings (1974). They were among the first to note only a partial restoration of coronary blood flow after the reperfusion of mechanically occluded for 90-180 minutes coronary artery in dogs. The authors considered damage to the capillary endothelium, edema of the damaged wall and extravasal tissues, and protrusion into the capillary cavity to be the cause of this phenomenon. The frequency of the phenomenon of «no-reflow» after the successful restoration of coronary blood flow in the IDCA varies between 5 - 40% of all cases. The development of this phenomenon was an unfavorable prognostic factor, primarily in terms of mortality and deterioration of the functional state of the left ventricle. The pathophysiology of the «no-reflow» phenomenon remains poorly understood. Obviously, it has a multifactorial nature and cannot be described by any one mechanism. Analyzing the phenomenon of «no-reflow», it is noted that in spite of the reperfusion of IDCA, there are pronounced pathophysiological changes in the microcirculatory tract, the essence of which is to block myocardial perfusion in the area of myocardial infarction. During the COVID-19 pandemic, the number of patients with myocardial infarction increased, including an increase in the number of diagnosed «no-reflow» and «slow-flow» phenomena, which is associated with the impact of SARS СOVID-19 virus on the myocardium, namely the development of microvascular damage. There is currently no specific therapy for the prevention and treatment of «no-reflow» phenomen that would be recommended for patients with STEMI. This article presents a clinical case of the phenomenon of «no-reflow» in patient B., 56 years old, who complained of severe chest pain, irradiation in the left shoulder and lower jaw, shortness of breath, general weakness. History of hypertension, coronavirus PCR +. Troponin I - 5.4 ng/ml. According to the electrocardiogram: elevation of the ST segment in II. III, aVF leads. At the time of contrast infusion during stenting of infarct-dependent right coronary artery, its slow filling was recorded - the phenomenon of «no-reflow» TIMI 0, MBG-0. The patient was discharged from the hospital in satisfactory condition under the supervision of a family doctor. Conclusions: The phenomenon of «no-reflow» is a topical and unresolved issue of myocardial...